We are live on ! Find out more
DS

DRW Securities Portfolio holdings

AUM $4.11B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
-10.41%
1 Year Est. Return
+21.98%
3 Year Est. Return
+96.16%
5 Year Est. Return
+100.81%
10 Year Est. Return
+306.64%
AUM
$903M
AUM Growth
-$17.9M
Cap. Flow
-$7.67M
Cap. Flow %
-0.85%
Top 10 Hldgs %
93.34%
Holding
139
New
30
Increased
24
Reduced
13
Closed
62

Sector Composition

Rank Sector Weight
1 Miscellaneous 96.17%
2 Financials 1.46%
3 Healthcare 1.33%
4 Industrials 0.34%
5 Technology 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RQI icon
101
Cohen & Steers Quality Income Realty Fund
RQI
$1.63B
-14,700
Closed -$157K
SJNK icon
102
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.75B
-99,865
Closed -$2.89M
SLV icon
103
iShares Silver Trust
SLV
$32.2B
-234,040
Closed -$3.33M
SPY icon
104
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$814B
-25,100
Closed -$5.17M
SPY icon
105
State Street SPDR S&P 500 ETF Trust
SPY
$814B
-17,701
Closed -$3.64M
SPY icon
106
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$814B
-25,100
Closed -$5.17M
TMV icon
107
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$201M
-12,690
Closed -$1.08M
TXN icon
108
Texas Instruments
TXN
$236B
-19,900
Closed -$1.02M
VGSH icon
109
Vanguard Short-Term Treasury ETF
VGSH
$34.7B
-7,713
Closed -$471K
VRTX icon
110
Vertex Pharmaceuticals
VRTX
$138B
-83,000
Closed -$10.2M
ZTS icon
111
CALL
Zoetis
ZTS
$31.3B
-9,900
Closed -$477K
RVNC
112
DELISTED
Revance Therapeutics, Inc.
RVNC
-34,000
Closed -$1.09M
PRTK
113
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-11,512
Closed -$297K
ADMS
114
DELISTED
Adamas Pharmaceuticals
ADMS
-21,800
Closed -$572K
MDCO
115
CALL
DELISTED
Medicines Co
MDCO
-38,400
Closed -$1.1M
CTRL
116
CALL
DELISTED
Control4 Corporation
CTRL
-16,000
Closed -$142K
HZNP
117
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-43,500
Closed -$1.51M
AET
118
CALL
DELISTED
Aetna Inc
AET
-6,800
Closed -$867K
KLXI
119
DELISTED
KLX Inc.
KLXI
-11,068
Closed -$412K
CAA
120
CALL
DELISTED
CalAtlantic Group, Inc.
CAA
-14,720
Closed -$656K
POT
121
CALL
DELISTED
Potash Corp Of Saskatchewan
POT
-16,500
Closed -$511K
ELOS
122
DELISTED
Syneron Medical Ltd
ELOS
-85,000
Closed -$903K
ZLTQ
123
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
-30,000
Closed -$884K
CSC
124
PUT
DELISTED
Computer Sciences
CSC
-18,747
Closed -$519K
CYNO
125
DELISTED
Cynosure, Inc. Class A
CYNO
-6,000
Closed -$231K

Similar funds

DRW Securities's Q3 2015 Portfolio in Review

As of Q3 2015, DRW Securities held 139 positions worth $903M, down 1.9% from $921M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

DRW Securities's Q3 2015 filing shows 30 new, 24 increased, 13 reduced and 62 closed positions. Its largest new stake was Gilead Sciences: 51,000 shares worth $5.01M. The largest sale was Vertex Pharmaceuticals, an estimated $10.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 94% a quarter earlier, followed by Financials and Healthcare.

  • DRW Securities's largest Q3 2015 buy was Gilead Sciences: 51,000 shares worth $5.01M.
  • DRW Securities added most to VelocityShares Daily Inverse VIX Short Term ETN in Q3 2015, an estimated $27.4M increase.
  • DRW Securities's biggest Q3 2015 reduction was Vanguard Total Bond Market, cutting an estimated $8.62M.
  • DRW Securities fully exited Vertex Pharmaceuticals in Q3 2015, selling an estimated $10.2M.
  • DRW Securities's ten largest holdings make up 93% of its $903M portfolio in Q3 2015.
  • DRW Securities opened 30 new positions and closed 62 in Q3 2015.
  • DRW Securities's portfolio value fell 1.9% quarter-over-quarter to $903M.

Based on DRW Securities's 13F filing for Q3 2015, filed 16 Nov 2015.